Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

In PAD, dropping statins ups death risk 43%

Publish date:: September 2, 2019

Key clinical point: Statin adherence saves lives in peripheral artery disease.

Major finding: Patients with PAD who stopped taking statins had an increase of 34%-43% in all-cause mortality.

Study details: Single site study of 691 patients with symptomatic PAD.

Disclosures: Dr. Dopheide reported that he had no outside sources of funding, and no conflicts of interest.

Citation:

Dopheide, J., et al. ESC Congress 2019, Abstract P5363.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Annual WCC visits significantly limit asthma worsening,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Microplastics permeate human placentas,

Must Reads in Cardiology

Sac/val heart failure benefit extends to diabetes patients,

Sedentary postmenopausal women have higher heart failure risk,

Experts disagree with USPSTF’s take on pediatric blood pressure screening,

GALACTIC-HF: New ‘myotropic’ drug class shows modest HFrEF benefit,

Don’t miss cardiovascular risk factors in transgender patients,